Contineum Therapeutics
CTNM
#7265
Rank
A$0.81 B
Marketcap
A$21.71
Share price
3.30%
Change (1 day)
271.86%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2025 (TTM): -A$92.77 Million

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$61.02 Million a decrease over its 2023 earnings that were of A$33.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$92.77 Million52.05%
2024 -A$61.02 Million-282.38%
2023 A$33.45 M